Gang Wu

Person

Princeton, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Multicyclic compounds as farnesoid X receptor modulators
- Patent number 11,370,785
- Issue date Jun 28, 2022
- Bristol-Myers Squibb Company
- Joseph E. Carpenter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spirocyclic compounds as farnesoid X receptor modulators
- Patent number 11,078,198
- Issue date Aug 3, 2021
- Bristol-Myers Squibb Company
- Joseph E. Carpenter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators
- Patent number 9,174,965
- Issue date Nov 3, 2015
- Bristol-Myers Squibb Company
- Matthias Broekema
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridone and pyridazone analogues as GPR119 modulators
- Patent number 8,372,837
- Issue date Feb 12, 2013
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indole indane amide compounds useful as CB2 agonists and method
- Patent number 7,943,658
- Issue date May 17, 2011
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyridine cannabinoid receptor 1 antagonists
- Patent number 7,572,808
- Issue date Aug 11, 2009
- Bristol-Myers Squibb Company
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-sulfonylpiperidine cannabinoid receptor 1 antagonists
- Patent number 7,517,991
- Issue date Apr 14, 2009
- Bristol-Myers Squibb Company
- Philip M. Sher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyrimidine cannabinoid receptor 1 antagonists
- Patent number 7,452,892
- Issue date Nov 18, 2008
- Bristol-Myers Squibb Company
- Gang Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lactam glycogen phosphorylase inhibitors and method of use
- Patent number 7,425,550
- Issue date Sep 16, 2008
- Bristol-Meyers Squibb Company
- Philip Sher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Azabicyclic heterocycles as cannabinoid receptor modulators
- Patent number 7,378,418
- Issue date May 27, 2008
- Bristol-Myers Squibb Company
- Guixue Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-Amino-3-functionalized tetralin derivatives and related glycogen...
- Patent number 7,365,061
- Issue date Apr 29, 2008
- Bristol-Myers Squibb Company
- Philip M. Sher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
- Patent number 7,276,608
- Issue date Oct 2, 2007
- Bristol-Myers Squibb Company
- Philip M. Sher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-Amino-1-functionalized tetralin derivatives and related glycogen...
- Patent number 7,214,704
- Issue date May 8, 2007
- Bristol-Myers Squibb Company
- Gang Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lactam glycogen phosphorylase inhibitors and method of use
- Patent number 7,057,046
- Issue date Jun 6, 2006
- Bristol-Myers Squibb Company
- Philip Sher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C-aryl glucoside SGLT2 inhibitors and method
- Patent number 6,936,590
- Issue date Aug 30, 2005
- Bristol-Myers Squibb Company
- William N. Washburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
O-aryl glucoside SGLT2 inhibitors and method
- Patent number 6,683,056
- Issue date Jan 27, 2004
- Bristol-Myers Squibb Company
- William N. Washburn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C-aryl glucoside SGLT2 inhibitors and method
- Patent number 6,515,117
- Issue date Feb 4, 2003
- Bristol-Myers Squibb Company
- Bruce Ellsworth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C-aryl glucoside SGLT2 inhibitors and method
- Patent number 6,414,126
- Issue date Jul 2, 2002
- Bristol-Myers Squibb Company
- Bruce Ellsworth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INTRAOPERATIVE 'NON-LIFTING' PERIPHERAL NERVE ACTION POTENTIAL RECO...
- Publication number 20220233125
- Publication date Jul 28, 2022
- The Johns Hopkins University
- Matthias Ringkamp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20210380578
- Publication date Dec 9, 2021
- Bristol-Myers Squibb Company
- Joseph E. Carpenter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20190127362
- Publication date May 2, 2019
- Bristol-Myers Squibb Company
- Joseph E. Carpenter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINYLPIPERIDINYLOXYPYRIDONE ANALOGUES AS GPR119 MODULATORS
- Publication number 20150133479
- Publication date May 14, 2015
- Bristol-Myers Squibb Company
- Matthias Broekema
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS
- Publication number 20130131074
- Publication date May 23, 2013
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS
- Publication number 20110263548
- Publication date Oct 27, 2011
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD
- Publication number 20090041722
- Publication date Feb 12, 2009
- Bristol -Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Triazolopyridine cannabinoid receptor 1 antagonists
- Publication number 20070004772
- Publication date Jan 4, 2007
- Chongqing Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Triazolopyrimidine cannabinoid receptor 1 antagonists
- Publication number 20060287341
- Publication date Dec 21, 2006
- Gang Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Lactam glycogen phosphorylase inhibitors and method of use
- Publication number 20060128687
- Publication date Jun 15, 2006
- Philip Sher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-Amino-1-functionalized tetralin derivatives and related glycogen...
- Publication number 20060111414
- Publication date May 25, 2006
- Gang Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-Amino-3-functionalized tetralin derivatives and related glycogen...
- Publication number 20060111413
- Publication date May 25, 2006
- Philip M. Sher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-sulfonylpiperidine cannabinoid receptor 1 antagonists
- Publication number 20060079556
- Publication date Apr 13, 2006
- Philip M. Sher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic heterocycles as cannabinoid receptor modulators
- Publication number 20050143381
- Publication date Jun 30, 2005
- Guixue Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
- Publication number 20050009870
- Publication date Jan 13, 2005
- Philip M. Sher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Lactam glycogen phosphorylase inhibitors and method of use
- Publication number 20040002495
- Publication date Jan 1, 2004
- Philip Sher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C-aryl glucoside SGLT2 inhibitors and method
- Publication number 20030114390
- Publication date Jun 19, 2003
- William N. Washburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C-aryl glucoside SGLT2 inhibitors and method
- Publication number 20020137903
- Publication date Sep 26, 2002
- Bruce Ellsworth
- C07 - ORGANIC CHEMISTRY
Information Patent Application
O-aryl glucoside SGLT2 inhibitors and method
- Publication number 20020111315
- Publication date Aug 15, 2002
- William N. Washburn
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Multicyclic compounds as farnesoid X receptor modulators

Spirocyclic compounds as farnesoid X receptor modulators

Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators

Pyridone and pyridazone analogues as GPR119 modulators

Indole indane amide compounds useful as CB2 agonists and method

Triazolopyridine cannabinoid receptor 1 antagonists

N-sulfonylpiperidine cannabinoid receptor 1 antagonists

Triazolopyrimidine cannabinoid receptor 1 antagonists

Lactam glycogen phosphorylase inhibitors and method of use

Azabicyclic heterocycles as cannabinoid receptor modulators

2-Amino-3-functionalized tetralin derivatives and related glycogen...

Tetrahydroquinoline derivatives as cannabinoid receptor modulators

2-Amino-1-functionalized tetralin derivatives and related glycogen...

Lactam glycogen phosphorylase inhibitors and method of use

C-aryl glucoside SGLT2 inhibitors and method

O-aryl glucoside SGLT2 inhibitors and method

C-aryl glucoside SGLT2 inhibitors and method

C-aryl glucoside SGLT2 inhibitors and method

Patents Applicationslast 30 patents

INTRAOPERATIVE 'NON-LIFTING' PERIPHERAL NERVE ACTION POTENTIAL RECO...

MULTICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SPIROCYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

PYRIMIDINYLPIPERIDINYLOXYPYRIDONE ANALOGUES AS GPR119 MODULATORS

PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS

PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS

INDOLE INDANE AMIDE COMPOUNDS USEFUL AS CB2 AGONISTS AND METHOD

Triazolopyridine cannabinoid receptor 1 antagonists

Triazolopyrimidine cannabinoid receptor 1 antagonists

Lactam glycogen phosphorylase inhibitors and method of use

2-Amino-1-functionalized tetralin derivatives and related glycogen...

2-Amino-3-functionalized tetralin derivatives and related glycogen...

N-sulfonylpiperidine cannabinoid receptor 1 antagonists

Azabicyclic heterocycles as cannabinoid receptor modulators

Tetrahydroquinoline derivatives as cannabinoid receptor modulators

Lactam glycogen phosphorylase inhibitors and method of use

C-aryl glucoside SGLT2 inhibitors and method

C-aryl glucoside SGLT2 inhibitors and method

O-aryl glucoside SGLT2 inhibitors and method